HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Radiotherapy in multilocalized lymphedema-associated angiosarcoma.

Abstract
We report an 80-year-old woman, suffering from a recurrence of a multilocalized lymphedema-associated angiosarcoma of the right arm. The tumor consisted of solid tumor cell formations and "classical" spongiform tumor complexes. In the tumor periphery, pathological endothelial cell proliferates on pre-existing dilated lymphatic capillaries were detectable, which, together with immunohistology (CD 31+/Desmoplakin-1-2.17+/CD 34-), supported the diagnosis of lymphangiosarcoma. Complete remission was achieved under radioimmunotherapy (54 Gy/Interferon beta). A further recurrence 3 months later outside the primary therapy fields was successfully treated with radiotherapy alone. During a follow-up observation period of 3 years, there was neither local recurrence nor metastasis. This case demonstrates for the first time the long-lasting efficacy of photon radiation in a case of histologically-defined lymphangiosarcoma. Further studies should elucidate the suitability of radio monotherapy as first-line therapy in lymphedema-associated angiosarcoma with lymphatic endothelium-like immunohistology.
AuthorsBeate Danz, Andrea Hellmann, Volker Stadie, Jürgen Dunst, Christine Richter, Wolfgang Ch Marsch, Peter Helmbold
JournalEuropean journal of dermatology : EJD (Eur J Dermatol) 2005 Nov-Dec Vol. 15 Issue 6 Pg. 474-7 ISSN: 1167-1122 [Print] France
PMID16280302 (Publication Type: Case Reports, Journal Article)
Topics
  • Aged
  • Aged, 80 and over
  • Female
  • Hemangiosarcoma (complications, pathology, radiotherapy)
  • Humans
  • Lymphedema (complications)
  • Skin Neoplasms (complications, pathology, radiotherapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: